Zobrazeno 1 - 10
of 21
pro vyhledávání: '"Thayer MB"'
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Barker SJ; Denali Therapeutics Inc., South San Francisco, CA, USA., Thayer MB; Denali Therapeutics Inc., South San Francisco, CA, USA., Kim C; Denali Therapeutics Inc., South San Francisco, CA, USA., Tatarakis D; Denali Therapeutics Inc., South San Francisco, CA, USA., Simon MJ; Denali Therapeutics Inc., South San Francisco, CA, USA., Dial R; Denali Therapeutics Inc., South San Francisco, CA, USA., Nilewski L; Denali Therapeutics Inc., South San Francisco, CA, USA., Wells RC; Denali Therapeutics Inc., South San Francisco, CA, USA., Zhou Y; Denali Therapeutics Inc., South San Francisco, CA, USA., Afetian M; Ionis Pharmaceuticals, Carlsbad, CA, USA., Akkapeddi P; Denali Therapeutics Inc., South San Francisco, CA, USA., Chappell A; Ionis Pharmaceuticals, Carlsbad, CA, USA., Chew KS; Denali Therapeutics Inc., South San Francisco, CA, USA., Chow J; Denali Therapeutics Inc., South San Francisco, CA, USA., Clemens A; Denali Therapeutics Inc., South San Francisco, CA, USA., Discenza CB; Denali Therapeutics Inc., South San Francisco, CA, USA., Dugas JC; Denali Therapeutics Inc., South San Francisco, CA, USA., Dwyer C; Ionis Pharmaceuticals, Carlsbad, CA, USA., Earr T; Denali Therapeutics Inc., South San Francisco, CA, USA., Ha C; Denali Therapeutics Inc., South San Francisco, CA, USA., Ho YS; Denali Therapeutics Inc., South San Francisco, CA, USA., Huynh D; Denali Therapeutics Inc., South San Francisco, CA, USA., Lozano EI; Denali Therapeutics Inc., South San Francisco, CA, USA., Jayaraman S; Denali Therapeutics Inc., South San Francisco, CA, USA., Kwan W; Denali Therapeutics Inc., South San Francisco, CA, USA., Mahon C; Denali Therapeutics Inc., South San Francisco, CA, USA., Pizzo M; Denali Therapeutics Inc., South San Francisco, CA, USA., Robles-Colmenares Y; Denali Therapeutics Inc., South San Francisco, CA, USA., Roche E; Denali Therapeutics Inc., South San Francisco, CA, USA., Sanders L; Denali Therapeutics Inc., South San Francisco, CA, USA., Stergioulis A; Denali Therapeutics Inc., South San Francisco, CA, USA., Tong R; Denali Therapeutics Inc., South San Francisco, CA, USA., Tran H; Denali Therapeutics Inc., South San Francisco, CA, USA., Zuchero Y; Denali Therapeutics Inc., South San Francisco, CA, USA., Estrada AA; Denali Therapeutics Inc., South San Francisco, CA, USA., Gadkar K; Denali Therapeutics Inc., South San Francisco, CA, USA., Koth CMM; Denali Therapeutics Inc., South San Francisco, CA, USA., Sanchez PE; Denali Therapeutics Inc., South San Francisco, CA, USA., Thorne RG; Denali Therapeutics Inc., South San Francisco, CA, USA., Watts RJ; Denali Therapeutics Inc., South San Francisco, CA, USA., Sandmann T; Denali Therapeutics Inc., South San Francisco, CA, USA., Kane LA; Denali Therapeutics Inc., South San Francisco, CA, USA., Rigo F; Ionis Pharmaceuticals, Carlsbad, CA, USA., Dennis MS; Denali Therapeutics Inc., South San Francisco, CA, USA., Lewcock JW; Denali Therapeutics Inc., South San Francisco, CA, USA., DeVos SL; Denali Therapeutics Inc., South San Francisco, CA, USA.
Publikováno v:
Science translational medicine [Sci Transl Med] 2024 Aug 14; Vol. 16 (760), pp. eadi2245. Date of Electronic Publication: 2024 Aug 14.
Autor:
Thayer MB; Tunis El Manar University, Faculty of Medicine of Tunis, Tunis, Tunisia; Salah Azaïez's Institute, Department of Pathology, Tunis, Tunisia. Electronic address: benthayerm@hotmail.com., Sahraoui G; Tunis El Manar University, Faculty of Medicine of Tunis, Tunis, Tunisia; Salah Azaïez's Institute, Department of Pathology, Tunis, Tunisia., Abouda HS; C Unit, Tunis Maternity and Neonatology Center, Tunis, Tunisia., Farhati M; C Unit, Tunis Maternity and Neonatology Center, Tunis, Tunisia., Doghri R; Tunis El Manar University, Faculty of Medicine of Tunis, Tunis, Tunisia; Salah Azaïez's Institute, Department of Pathology, Tunis, Tunisia., Mrad K; Tunis El Manar University, Faculty of Medicine of Tunis, Tunis, Tunisia; Salah Azaïez's Institute, Department of Pathology, Tunis, Tunisia.
Publikováno v:
International journal of surgery case reports [Int J Surg Case Rep] 2024 Apr; Vol. 117, pp. 109457. Date of Electronic Publication: 2024 Mar 04.
Autor:
Thayer MB; TB Discovery Research, Infectious Disease Research Institute, Seattle, WA, United States of America., Parish T; TB Discovery Research, Infectious Disease Research Institute, Seattle, WA, United States of America.; Center for Global Infectious Disease Research, Seattle Children's Research Institute, Seattle, WA, United States of America.
Publikováno v:
PloS one [PLoS One] 2021 Jan 22; Vol. 16 (1), pp. e0239353. Date of Electronic Publication: 2021 Jan 22 (Print Publication: 2021).
Autor:
Basiri B; Amgen Research, Pharmacokinetics and Drug Metabolism, 1120 Veterans Blvd., South San Francisco, CA 94080, USA. Electronic address: bbasiri@amgen.com., Xie F; Amgen Research, Pharmacokinetics and Drug Metabolism, 1120 Veterans Blvd., South San Francisco, CA 94080, USA., Wu B; Amgen Research, Hybrid Modality Engineering, One Amgen Center Drive, Thousand Oaks, CA 91320, USA., Humphreys SC; Amgen Research, Pharmacokinetics and Drug Metabolism, 1120 Veterans Blvd., South San Francisco, CA 94080, USA., Lade JM; Amgen Research, Pharmacokinetics and Drug Metabolism, 1120 Veterans Blvd., South San Francisco, CA 94080, USA., Thayer MB; Amgen Research, Pharmacokinetics and Drug Metabolism, 1120 Veterans Blvd., South San Francisco, CA 94080, USA., Yamaguchi P; Amgen Research, Cardiometabolic Disorders, One Amgen Center Drive, Thousand Oaks, CA 91320, USA., Florio M; Amgen Research, Cardiometabolic Disorders, One Amgen Center Drive, Thousand Oaks, CA 91320, USA., Rock BM; Amgen Research, Pharmacokinetics and Drug Metabolism, 1120 Veterans Blvd., South San Francisco, CA 94080, USA.
Publikováno v:
Molecular therapy. Nucleic acids [Mol Ther Nucleic Acids] 2020 Sep 04; Vol. 21, pp. 725-736. Date of Electronic Publication: 2020 Jul 10.
Autor:
Thayer MB; Amgen Research, Pharmacokinetics & Drug Metabolism, Amgen Inc., South San Francisco, CA, US., Humphreys SC; Amgen Research, Pharmacokinetics & Drug Metabolism, Amgen Inc., South San Francisco, CA, US., Chung KS; Amgen Research, Pharmacokinetics & Drug Metabolism, Amgen Inc., South San Francisco, CA, US., Lade JM; Amgen Research, Pharmacokinetics & Drug Metabolism, Amgen Inc., South San Francisco, CA, US., Cook KD; Amgen Research, Pharmacokinetics & Drug Metabolism, Amgen Inc., South San Francisco, CA, US., Rock BM; Amgen Research, Pharmacokinetics & Drug Metabolism, Amgen Inc., South San Francisco, CA, US. brooke@amgen.com.
Publikováno v:
Scientific reports [Sci Rep] 2020 Jun 26; Vol. 10 (1), pp. 10425. Date of Electronic Publication: 2020 Jun 26.
Autor:
Humphreys SC; Pharmacokinetics and Drug Metabolism Department, Amgen Research, 1120 Veterans Boulevard, South San Francisco, California 94080, United States., Thayer MB; Pharmacokinetics and Drug Metabolism Department, Amgen Research, 1120 Veterans Boulevard, South San Francisco, California 94080, United States., Campbell J; Neuroscience Department, Amgen Research, 360 Binney Street, Cambridge, Massachusetts 02141, United States., Chen WLK; Comparative Biology and Safety Sciences Department, Amgen Research, 360 Binney Street, Cambridge, Massachusetts 02141, United States., Adams D; Comparative Biology and Safety Sciences Department, Amgen Research, 360 Binney Street, Cambridge, Massachusetts 02141, United States., Lade JM; Pharmacokinetics and Drug Metabolism Department, Amgen Research, 1120 Veterans Boulevard, South San Francisco, California 94080, United States., Rock BM; Pharmacokinetics and Drug Metabolism Department, Amgen Research, 1120 Veterans Boulevard, South San Francisco, California 94080, United States.
Publikováno v:
Journal of medicinal chemistry [J Med Chem] 2020 Jun 25; Vol. 63 (12), pp. 6407-6422. Date of Electronic Publication: 2020 May 26.
Autor:
Humphreys SC; Pharmacokinetics and Drug Metabolism Department, Amgen Research, South San Francisco, California (S.C.H., M.B.T., J.M.L., B.B., R.S., B.M.R.); Hybrid Modality Engineering Department, Amgen Research, Thousand Oaks, California (B.W., K.S.); and Molecular Engineering Department, Amgen Research, Cambridge, Massachusetts (Y.H., X.H.) shumph01@amgen.com., Thayer MB; Pharmacokinetics and Drug Metabolism Department, Amgen Research, South San Francisco, California (S.C.H., M.B.T., J.M.L., B.B., R.S., B.M.R.); Hybrid Modality Engineering Department, Amgen Research, Thousand Oaks, California (B.W., K.S.); and Molecular Engineering Department, Amgen Research, Cambridge, Massachusetts (Y.H., X.H.)., Lade JM; Pharmacokinetics and Drug Metabolism Department, Amgen Research, South San Francisco, California (S.C.H., M.B.T., J.M.L., B.B., R.S., B.M.R.); Hybrid Modality Engineering Department, Amgen Research, Thousand Oaks, California (B.W., K.S.); and Molecular Engineering Department, Amgen Research, Cambridge, Massachusetts (Y.H., X.H.)., Wu B; Pharmacokinetics and Drug Metabolism Department, Amgen Research, South San Francisco, California (S.C.H., M.B.T., J.M.L., B.B., R.S., B.M.R.); Hybrid Modality Engineering Department, Amgen Research, Thousand Oaks, California (B.W., K.S.); and Molecular Engineering Department, Amgen Research, Cambridge, Massachusetts (Y.H., X.H.)., Sham K; Pharmacokinetics and Drug Metabolism Department, Amgen Research, South San Francisco, California (S.C.H., M.B.T., J.M.L., B.B., R.S., B.M.R.); Hybrid Modality Engineering Department, Amgen Research, Thousand Oaks, California (B.W., K.S.); and Molecular Engineering Department, Amgen Research, Cambridge, Massachusetts (Y.H., X.H.)., Basiri B; Pharmacokinetics and Drug Metabolism Department, Amgen Research, South San Francisco, California (S.C.H., M.B.T., J.M.L., B.B., R.S., B.M.R.); Hybrid Modality Engineering Department, Amgen Research, Thousand Oaks, California (B.W., K.S.); and Molecular Engineering Department, Amgen Research, Cambridge, Massachusetts (Y.H., X.H.)., Hao Y; Pharmacokinetics and Drug Metabolism Department, Amgen Research, South San Francisco, California (S.C.H., M.B.T., J.M.L., B.B., R.S., B.M.R.); Hybrid Modality Engineering Department, Amgen Research, Thousand Oaks, California (B.W., K.S.); and Molecular Engineering Department, Amgen Research, Cambridge, Massachusetts (Y.H., X.H.)., Huang X; Pharmacokinetics and Drug Metabolism Department, Amgen Research, South San Francisco, California (S.C.H., M.B.T., J.M.L., B.B., R.S., B.M.R.); Hybrid Modality Engineering Department, Amgen Research, Thousand Oaks, California (B.W., K.S.); and Molecular Engineering Department, Amgen Research, Cambridge, Massachusetts (Y.H., X.H.)., Smith R; Pharmacokinetics and Drug Metabolism Department, Amgen Research, South San Francisco, California (S.C.H., M.B.T., J.M.L., B.B., R.S., B.M.R.); Hybrid Modality Engineering Department, Amgen Research, Thousand Oaks, California (B.W., K.S.); and Molecular Engineering Department, Amgen Research, Cambridge, Massachusetts (Y.H., X.H.)., Rock BM; Pharmacokinetics and Drug Metabolism Department, Amgen Research, South San Francisco, California (S.C.H., M.B.T., J.M.L., B.B., R.S., B.M.R.); Hybrid Modality Engineering Department, Amgen Research, Thousand Oaks, California (B.W., K.S.); and Molecular Engineering Department, Amgen Research, Cambridge, Massachusetts (Y.H., X.H.).
Publikováno v:
Drug metabolism and disposition: the biological fate of chemicals [Drug Metab Dispos] 2019 Oct; Vol. 47 (10), pp. 1174-1182. Date of Electronic Publication: 2019 May 16.
Autor:
Humphreys SC; 1 Amgen, Inc., Pharmacokinetics and Drug Metabolism, Amgen Research, South San Francisco, California., Thayer MB; 1 Amgen, Inc., Pharmacokinetics and Drug Metabolism, Amgen Research, South San Francisco, California., Campuzano IDG; 2 Amgen, Inc., Discovery Attribute Sciences, Amgen Research, Thousand Oaks, California., Netirojjanakul C; 3 Amgen, Inc., Hybrid Modality Engineering, Amgen Research, Thousand Oaks, California., Rock BM; 1 Amgen, Inc., Pharmacokinetics and Drug Metabolism, Amgen Research, South San Francisco, California.
Publikováno v:
Nucleic acid therapeutics [Nucleic Acid Ther] 2019 Jun; Vol. 29 (3), pp. 161-166. Date of Electronic Publication: 2019 Mar 12.
Autor:
Thayer MB; Amgen Research, Pharmacokinetics and Drug Metabolism, South San Francisco, 94080, USA. mthayer@amgen.com., Lade JM; Amgen Research, Pharmacokinetics and Drug Metabolism, South San Francisco, 94080, USA., Doherty D; Amgen Research, Pharmacokinetics and Drug Metabolism, South San Francisco, 94080, USA., Xie F; Amgen Research, Pharmacokinetics and Drug Metabolism, South San Francisco, 94080, USA., Basiri B; Amgen Research, Pharmacokinetics and Drug Metabolism, South San Francisco, 94080, USA., Barnaby OS; Amgen Research, Pharmacokinetics and Drug Metabolism, Thousand Oaks, 91320, USA., Bala NS; Amgen Research, Pharmacokinetics and Drug Metabolism, South San Francisco, 94080, USA., Rock BM; Amgen Research, Pharmacokinetics and Drug Metabolism, South San Francisco, 94080, USA. brooke@amgen.com.
Publikováno v:
Scientific reports [Sci Rep] 2019 Mar 05; Vol. 9 (1), pp. 3566. Date of Electronic Publication: 2019 Mar 05.